No abstract available
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Brain / drug effects*
-
Brain / pathology*
-
Double-Blind Method
-
Drug Administration Schedule
-
Female
-
Humans
-
Immunologic Factors / administration & dosage
-
Immunologic Factors / adverse effects
-
Longitudinal Studies
-
Magnetic Resonance Imaging
-
Male
-
Multiple Sclerosis / drug therapy*
-
Multiple Sclerosis / pathology*
-
Multiple Sclerosis / physiopathology
-
Natalizumab
-
Nerve Fibers, Myelinated / drug effects
-
Nerve Fibers, Myelinated / immunology
-
Nerve Fibers, Myelinated / pathology
-
Placebos
-
Recurrence
-
Substance Withdrawal Syndrome / pathology*
-
Substance Withdrawal Syndrome / physiopathology
-
Time
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunologic Factors
-
Natalizumab
-
Placebos